DE60302217D1 - Trizyklo-imidazolinen derivaten, verfahren zu deren herstellung und deren verwendung als heilmitteln - Google Patents

Trizyklo-imidazolinen derivaten, verfahren zu deren herstellung und deren verwendung als heilmitteln

Info

Publication number
DE60302217D1
DE60302217D1 DE60302217T DE60302217T DE60302217D1 DE 60302217 D1 DE60302217 D1 DE 60302217D1 DE 60302217 T DE60302217 T DE 60302217T DE 60302217 T DE60302217 T DE 60302217T DE 60302217 D1 DE60302217 D1 DE 60302217D1
Authority
DE
Germany
Prior art keywords
sub
trizyklo
medicaments
production
och
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60302217T
Other languages
English (en)
Inventor
Bernard Vacher
Bernard Bonnaud
Marc Marien
Thierry Imbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of DE60302217D1 publication Critical patent/DE60302217D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60302217T 2002-02-14 2003-02-14 Trizyklo-imidazolinen derivaten, verfahren zu deren herstellung und deren verwendung als heilmitteln Expired - Lifetime DE60302217D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0201839A FR2835834B1 (fr) 2002-02-14 2002-02-14 Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments
PCT/FR2003/000480 WO2003068755A1 (fr) 2002-02-14 2003-02-14 Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments

Publications (1)

Publication Number Publication Date
DE60302217D1 true DE60302217D1 (de) 2005-12-15

Family

ID=27620209

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60302217T Expired - Lifetime DE60302217D1 (de) 2002-02-14 2003-02-14 Trizyklo-imidazolinen derivaten, verfahren zu deren herstellung und deren verwendung als heilmitteln

Country Status (13)

Country Link
US (1) US20050107455A1 (de)
EP (1) EP1476433B1 (de)
JP (1) JP2005525342A (de)
CN (1) CN1646496A (de)
AT (1) ATE309221T1 (de)
AU (1) AU2003226482A1 (de)
BR (1) BR0307671A (de)
CA (1) CA2475880A1 (de)
DE (1) DE60302217D1 (de)
FR (1) FR2835834B1 (de)
MX (1) MXPA04007856A (de)
WO (1) WO2003068755A1 (de)
ZA (1) ZA200406445B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2323734A1 (de) * 2008-08-04 2011-05-25 Schering Corporation Cyclopropylchromen-derivate als modulatoren des alpha-2c-rezeptors
CN103360360A (zh) * 2012-04-10 2013-10-23 肖竹平 一种基于二氢杨梅素制备(+)-没食子儿茶素的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE302757T1 (de) * 2000-05-08 2005-09-15 Orion Corp Neue polyzyklische indanylimidazole mit alpha2 adrenergik aktivität

Also Published As

Publication number Publication date
CA2475880A1 (fr) 2003-08-21
EP1476433A1 (de) 2004-11-17
WO2003068755A1 (fr) 2003-08-21
JP2005525342A (ja) 2005-08-25
FR2835834A1 (fr) 2003-08-15
AU2003226482A1 (en) 2003-09-04
ATE309221T1 (de) 2005-11-15
ZA200406445B (en) 2005-06-14
BR0307671A (pt) 2005-01-04
EP1476433B1 (de) 2005-11-09
CN1646496A (zh) 2005-07-27
FR2835834B1 (fr) 2004-04-02
MXPA04007856A (es) 2004-10-15
US20050107455A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
MEP7808A (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
ATE533775T1 (de) Verfahren zur herstellung von 17-vinyl-triflaten als intermediate
NO20062644L (no) DPP-IV inhibitorer
UA88163C2 (ru) Cgrp-антагонисты, способ их получения, а также их применение как лекарственных средств
GB0719180D0 (en) New process
CO5700820A2 (es) Derivados de dioxan-2-alquilcarbamatos, su preparacion y su aplicacion en terapeutica
DE60123911D1 (de) Verfahren zur Herstellung von Aryloctanoyl-amiden
NO20076680L (no) Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter
ATE442849T1 (de) Wässrige zusammensetzung mit einem thiazol- derivat
BRPI0406500A (pt) processo farmacêutico e compostos preparados pelo mesmo
ATE495158T1 (de) Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
MXPA05013631A (es) Derivado heterociclico de metilsulfona.
WO2008149834A1 (ja) ピリミドジアゼピノン誘導体
EA200500237A1 (ru) Новый способ синтеза соединений 1,3-дигидро-2h-3-бензазепин-2-она и применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
CO5660258A2 (es) Derivados de imidazol iii
WO2008068423A3 (fr) Derives de pyrrole, leur preparation et leur utilisation en therapeutique.
DE60302217D1 (de) Trizyklo-imidazolinen derivaten, verfahren zu deren herstellung und deren verwendung als heilmitteln
AR028740A1 (es) Procedimiento para la preparacion de pirazolopirimidinonas
ATE383353T1 (de) Verfahren zur herstellung von 2-alkyl-3- aminothiophen derivate und 3-aminothiophen derivate
ATE286050T1 (de) Heterozyclische oder benzol derivate von liponsäure, deren herstellung und deren verwendung als heilmittel
HRP20030381B1 (en) 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
EE200300090A (et) Asendatud imidasopüridiinühendite valmistamise meetod
DE60321724D1 (de) 1,2-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
ATE340175T1 (de) Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase

Legal Events

Date Code Title Description
8332 No legal effect for de